2023-10-23 | NDAQ:IRWD | Press Release | Ironwood Pharmaceuticals Inc
(2023-10-23 | NDAQ:IRWD) Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting
Source: stockhouse.com
📰 Boxed Warning News
Page 15 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting
– Data reinforce the impact of linaclotide on symptoms of IBS-C and CIC – – Additional studies highlight the burden of these disorders on patients – ...
Source: marketscreener.com
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that three posters detailing findings from...
Source: prnewswire.com
UCB announces U.S. FDA approval of ZILBRYSQ® (zilucoplan) for the treatment of adults with generalized myasthenia gravis
FDA approval of ZILBRYSQ® (zilucoplan) has been granted for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-ac...
Source: businessinsider.com
UCB : announces U.S. FDA approval of ZILBRYSQ (zilucoplan) for the treatment of adults with generalized myasthenia gravis -October 17, 2023 at 06:04 pm EDT
UCB announces U.S. FDA approval of ZILBRYSQ[®] for the treatment of adults with generalized myasthenia gravis FDA approval of ZILBRYSQ® has been granted...
Bruxelles Capitale Howard Jf Jr Iris Loew Friedrich Eculizumab Soliris Daphne Teo Jean Christophe Tellier
Source: marketscreener.com
Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 14 abstracts from across its sleep...
Source: prnewswire.com
Zilbrysq Gets FDA Approval for Generalized Myasthenia Gravis
The FDA has approved Zilbrysq (zilucoplan) for generalized myasthenia gravis in patients who are AChR antibody positive.
Source: empr.com
Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® ...
Jay is sharing his story of receiving an ADHD diagnosis and eventually finding his treatment approach with Qelbree15.7 million U.S. children, teens and adults estimated to have been diagnosed with
Source: eagletribune.com
UCB announces U.S. FDA approval of ZILBRYSQ® (zilucoplan) for the treatment of adults with generalized myasthenia gravis
FDA approval of ZILBRYSQ® has been granted for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody-positive1ZILBRYSQ is the first...
Source: marketscreener.com